Trifluoroacetic acid → HCID 59267851, compound
Reaction equation
C(O)(C(F)(F)F)=O.C(OC(=O)[NH:14][C:15]1[S:16][C:17]([C:20]([CH3:41])([CH3:40])[CH2:21][O:22][Si:23]([C:36]([CH3:39])([CH3:38])[CH3:37])([C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)=[N:18][N:19]=1)(C)(C)C>C(Cl)Cl>[C:36]([Si:23]([C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1)([C:30]1[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=1)[O:22][CH2:21][C:20]([C:17]1[S:16][C:15]([NH2:14])=[N:19][N:18]=1)([CH3:41])[CH3:40])([CH3:37])([CH3:38])[CH3:39]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A 10% solution of TFA in DCM (720 mL) is added at 0° C. to a solution of {5-[2-(tert-Butyl-diphenyl-silanyloxy)-1,1-dimethyl-ethyl]-1,3,4-thiadiazol-2-yl}-carbamic acid tert-butyl ester (12.0 g, 23.4 mmol) in DCM (800 mL). The reaction mixture is stirred at room temperature for 14 h. The solvent is removed under reduced pressure and the crude purified by column chromatography to afford 8.8 g of 5-[2-(tert-butyl-diphenyl-silanyloxy)-1,1-dimethyl-ethyl]-1,3,4-thiadiazol-2-ylamine as a viscous liquid. Yield: 91%; 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1.05 (9H, s), 1.30 (6H, s), 3.60 (2H, s), 7.30-7.50 (6H, m), 7.50-7.70 (4H, m), 9.00 (2H, s); m/z 412 [M+H].
Workup
- customThe solvent is removed under reduced pressure
- customthe crude purified by column chromatography
Sources & evidence
- ORD record
- ord-0b7d98a1b18f48d8b876bca73aa5238b
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08362039B2
Reaction notes
Loading…